FDA expands approval for GSK’s RSV vaccine to cover younger at-risk adults
Posted:
The Food and Drug Administration expanded the approval for GSK’s vaccine to protect against respiratory syncytial virus, or RSV, authorizing its use for at-risk adults as young as 50.
Tees, Esk and Wear Valleys NHS Foundation Trust has signed a contract with the Access Group to introduce its electronic patient record system.
Nick Black, CIO and senior information risk owner at Tees, Esk and Wear Valleys NHS has taken…
Internationally renowned surgeon and innovator Prof Shafi Ahmed has published his new book, INTELLIGENT: The Evolution of AI Transforming Healthcare, offering a powerful and timely exploration of how artificial intelligence is reshaping modern medicine.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us